Daniel Agnew

Daniel Agnew is a self-directed and experienced corporate development and intellectual property professional currently serving as the Global Head of Dia IP Administration at Roche. They possess a broad knowledge of the biotech industry and hold a PhD in Chemical Engineering and the status of a registered US Patent Agent. Previously, Daniel held various roles including Director of Corporate Development at Nimble Therapeutics and multiple positions at Roche, where they led a global team and managed extensive patent portfolios. Their career also includes research experience at the University of Illinois at Urbana-Champaign and a patent agent role at Quarles & Brady LLP.